Krystal Biotech Launches Spinoff for Gene-Based Anti-Wrinkle ProductsAesthetics, Business, Company Launches, Gene Therapy, New Subsidiaries, R&D, Rare Diseases, Skin Conditions, Spin-Offs, WrinklesOn the back of a $135 million public offering in February, rare disease gene therapy company Krystal Biotech Inc. launched subsidiary Jeune Inc. to promote gene therapies for aesthetic skin conditions. Read more March 25, 2021/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2021/03/Krystal-Biotech-Launches-Spinoff-for-Gene-Based-Anti-Wrinkle-Products-BioSpace-3-25-21.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2021-03-25 11:54:202021-03-25 11:55:11Krystal Biotech Launches Spinoff for Gene-Based Anti-Wrinkle Products